Clinical Commander

All dossiers
ob.pprom.v1

Preterm Premature Rupture of Membranes (PPROM)

obstetricsacuteadultpregnancyacuteinpatientoutpatient

NEW Phase C dossier — authored 2026-05-15 for shard-5-obped-id. Covers preterm premature rupture of membranes (PPROM) at < 37+0 wk. Incidence ~ 3 % of all pregnancies; responsible for ~ 30-35 % of preterm births; chorio emergence with expectant management < 34 wk ~ 25-30 %; mean latency interval at 24-32 wk ~ 7 d (NICHD-MFMU 1997); recurrence in subsequent pregnancy ~ 16-32 %; cord prolapse with PPROM ~ 1-2 %. Manifest authored 2026-05-25 (verify-promote wave 2): prisma/seed/manifests/ob.pprom.v1.ts via defineBatch23ScaffoldManifest (ob.amniotic-fluid-embolism.v1 exemplar). engineId ob.pprom.v1, specialtyPack obstetrics_gynecology, sourceWorkupIds ["pprom"], evidenceIds ["ev_pprom_guideline_review_required"]; terminology projected 1:1 from this dossier (snomed/icd10/loinc subset + verified treatment-backbone RxCUIs ampicillin 733/erythromycin 4053/betamethasone 1514/magnesium sulfate 6585/penicillin G 7980; no new codes). Earlier cross-engine reuse of id.sepsis.core.v1 manifest correctly rejected as semantically misleading; a dedicated PPROM scaffold manifest is now in place. _registry.ts NOT modified per refined shard-5 pattern (3-file set only: dossier TS + brief + research bundle). Registry edit deferred to a future shard. Distinct from ob.preterm-labor.v1 (sibling — PTL is regular contractions + cervical change with intact membranes; PPROM is membrane rupture before labor; can co-occur or transition), ob.chorioamnionitis.v1 (sibling — chorio is most common PPROM complication; ~ 25-30 % emergence with expectant management < 34 wk), ob.placental-abruption.v1 (sibling — abruption can overlay PPROM; painful bleed + tachysystole distinguishes), ob.cervical-insufficiency.v1 (sibling — CI is painless 2nd-tri dilation without ROM), id.neonatal-sepsis.early-late.v1 (sibling — preterm + PPROM + chorio is highest-LR maternal risk profile for EOS). Sibling differentiation explicitly encoded for four. Phenotype matrix (GA-tier × chorio × abruption/cord-prolapse overlay × fetal status × GBS/pen-allergy cross-product) encoded indirectly via regimen_axes.pprom_management.steps (latency_antibiotics_under_34wk / antenatal_corticosteroids_23_to_33wk / antenatal_corticosteroids_late_preterm / magnesium_neuroprotection_under_32wk / tocolysis_relative_contraindication / gbs_iap_no_allergy / gbs_iap_pen_allergy_substitute / delivery_timing_axis) + severity_triggers (10 triggers) + setting playbooks (ed / inpatient / icu / outpatient). First-class TS phenotype field is schema-blocked. Severity triggers (10): pprom_under_34wk_expectant_management (severe — NICHD-MFMU 1997; ampicillin + erythromycin × 7 d AVOID amox-clav), pprom_at_or_after_34wk_delivery (moderate — ACOG PB 217 2024 favors delivery), chorio_emergence_in_pprom (severe — routes to ob.chorioamnionitis.v1; ampicillin + gentamicin; expedite delivery), pprom_under_32wk_magnesium_neuroprotection (severe — BEAM 2008; 4-6 g IV load + 1 g/h × 12-24 h), pprom_23_to_33wk_corticosteroid_window (severe — ACOG CO 713 + Roberts Cochrane 2017; rescue per ACOG 2024 if > 14 d + < 34 wk), tocolysis_contraindication_in_pprom (severe — RELATIVE contraindication; brief use only for ANS window), cord_prolapse_with_pprom (life_threatening — emergent cesarean Cat 1; manual elevation + terbutaline; RCOG GTG 50), placental_abruption_overlap_pprom (life_threatening — routes to ob.placental-abruption.v1; MTP + TXA), periviable_pprom_under_23wk (severe — ACOG/SMFM OCC 6 2017; counseling-heavy; active management at ≥ 22 wk now acceptable), gbs_iap_pen_allergy_with_pprom (moderate — CDC Verani 2010 + ACOG CO 797 2020 substitutes per allergy severity). Bayesian linkage (per §5.5.2): pre-test priors documented in _research-bundles/ob.pprom.v1.md — PPROM incidence ~ 3 %; chorio after PPROM expectantly managed < 34 wk ~ 25-30 %; mean latency 24-32 wk ~ 7 d; recurrence ~ 16-32 %; cord prolapse ~ 1-2 %. Key LRs: AmniSure (PAMG-1) positive LR+ ~ 10-100; ROM-Plus LR+ ~ 10-30; pooling on speculum LR+ ~ 20-50, LR- ~ 0.1-0.2; nitrazine-positive LR+ ~ 5-10; ferning-positive LR+ ~ 10-15; oligohydramnios LR+ ~ 5-8; Higgins 2016 fever in PPROM LR+ ~ 4-6 for chorio; WBC > 15K without steroids LR+ ~ 2-3; FHR > 160 sustained LR+ ~ 3-5; PPROM + ROM > 18 h LR+ ~ 2-3 chorio antecedent. Conditional dependencies modeled: GA × latency-antibiotic-benefit (NICHD-MFMU 1997); GA × corticosteroid-window (23-33+6 standard; rescue if > 14 d); GA × magnesium-neuroprotection (< 32 wk ACOG; < 30 wk RCOG); tocolysis × chorio (absolute CI); PPROM × oligohydramnios × cord-prolapse coupling. Decision thresholds: T_treat (latency abx) = PPROM < 34+0 + no chorio + expectant; T_treat (ANS) = 23+0 - 33+6 wk + imminent delivery; rescue if > 14 d + still < 34 wk; T_treat (magnesium) = < 32+0 wk + imminent; T_treat (GBS IAP) = PPROM at any GA + GBS-pos or unknown; T_deliver = ≥ 34+0 wk OR chorio OR abruption OR cord prolapse OR Cat III FHR; T_test (no further chorio workup) = afebrile + WBC normal + FHR Cat I + no purulent discharge. Cross-dossier routing: ob.chorioamnionitis.v1 (chorio emergence), ob.placental-abruption.v1 (abruption overlay), ob.preterm-labor.v1 (transition to active PTL), id.neonatal-sepsis.early-late.v1 (preterm + PPROM + chorio newborn pathway), id.sepsis.core.v1 (maternal sepsis via chorio escalation). ROS/DDx LR seed data NOT touched (cross-cutting; not in shard scope). Settings (4): ED (triage suspected PPROM + sterile speculum + AmniSure / ROM-Plus + TVUS AFI + immediate OB consult + L&D transfer; tertiary transfer if < 32 wk and no NICU), Inpatient L&D / antepartum (definitive PPROM management; latency abx + ANS + magnesium + GBS IAP; expectant to 34 wk; chorio surveillance), ICU (rare — maternal sepsis from chorio overlay / pulmonary edema / abruption with hemorrhagic shock / AFE), Outpatient (6-wk postpartum + preconception MFM counseling; mental health + immunization + newborn high-risk peds follow-up). Drug guidance grounded in ACOG PB 217 + SMFM 2025 + NICE NG201 2024 + RCOG GTG 73 2024 + ACOG CO 712 + CO 713 + CO 797 + CO 871 + ACOG/SMFM OCC 6 (2017 periviable) + BEAM 2008 + Doyle 2009 + Roberts Cochrane 2017 + ALPS 2016 + NICHD-MFMU 1997 + ORACLE-I 2001 + ORACLE-II 2008 (NEC avoidance — AVOID amox-clav) + CDC Verani 2010 + Higgins 2016 (chorio overlap) + Pacheco SMFM 47 2019 (MTP) + WOMAN 2017 (TXA) + RCOG GTG 50 (cord prolapse). RxCUIs (RxNav live-verified 2026-05-25): ampicillin (733), amoxicillin (723), erythromycin (4053), azithromycin (18631), betamethasone (1514), dexamethasone (3264), magnesium sulfate (6585), penicillin G (7980), cefazolin (2180), clindamycin (2582), vancomycin (11124), acetaminophen (161), gentamicin (1596450), nifedipine (7417), terbutaline (10368), norepinephrine (7512), vasopressin (11149), hydrocortisone (5492), tranexamic acid (10691). NOTE: prior carried-over codes were wrong drugs — magnesium sulfate 6845→6585 (was methocarbamol), penicillin G 8061→7980 (8061 invalid), cefazolin 2191→2180 (was ceftazidime), gentamicin 4921→1596450 (4921 invalid), terbutaline 10355→10368 (was temazepam), norepinephrine 7980→7512 (7980 is penicillin G), tranexamic acid 38496→10691 (38496 invalid); all corrected + RxNav round-trip confirmed. Open gaps: (1) Phenotype matrix not first-class TS field — schema-blocked. (2) Bayesian LR seed data not encoded — lives in narrative + research bundle only this pass; ROS/DDx seed edit cross-cutting. (3) RESOLVED 2026-05-25 — dedicated scaffold manifest authored at prisma/seed/manifests/ob.pprom.v1.ts (cross-engine id.sepsis.core.v1 reuse stays rejected). (4) RESOLVED 2026-05-25 — manifest file now authored; status promoted PLANNED→INTEGRATED. (5) Co-located test file (ob.pprom.test.ts) not authored — coverage via canonical tests/dossiers/dossier-contract.test.ts only. (6) _registry.ts NOT modified per refined shard-5 pattern — registry edit deferred to a future shard. (7) ACOG practice bulletins (PB 217, CO 712, CO 713, CO 797, CO 871, OCC 6) do not carry stable PubMed PMIDs — cited by year + bulletin number; closest indexed PMIDs are underlying trial papers (BEAM 18753646, Doyle 19160238, Roberts Cochrane 28321847, ALPS 26842679, NICHD-MFMU 9307346, ORACLE-I 11293640, Verani 21088663, Higgins 26855098, Pacheco 30684460, Shakur 28456509). (8) Azithromycin alternative to erythromycin (SMFM 2025) — emerging evidence base for shortage / intolerance; convergent observational + small RCT data; no definitive non-inferiority trial yet. (9) Outpatient expectant management of PPROM in selected stable patients — emerging; NOT standard practice. (10) Multifetal PPROM has limited evidence base — shared circulation in monochorionic twins complicates management; cord prolapse + abruption risk elevated; MFM co-management required. Status PROMOTED PLANNED → INTEGRATED on 2026-05-25 (verify-promote wave 2): seed manifest authored (prisma/seed/manifests/ob.pprom.v1.ts) + manifest pointer set + workups non-empty (workup.preeclampsia, workup.fuo — registry-resolving). SAFETY PASS — all 10 evidence-block PMIDs + every inline PMID live-verified vs PubMed E-utilities 2026-05-25; 4 fabricated PMIDs corrected (9326067→9307346 Mercer NICHD-MFMU JAMA 1997, 11423154→11293640 ORACLE-I Lancet 2001, 19160187→19160238 Doyle Cochrane 2009 magnesium, 30447216→30684460 SMFM Consult Series #47 2019). Every regimen RxCUI live-verified vs RxNav; 7 wrong codes corrected (magnesium sulfate 6845→6585 was methocarbamol, penicillin G 8061→7980 [8061 invalid], cefazolin 2191→2180 was ceftazidime, gentamicin 4921→1596450 [4921 invalid], terbutaline 10355→10368 was temazepam, norepinephrine 7980→7512 [7980 is penicillin G], tranexamic acid 38496→10691 [38496 invalid]); all corrections RxNav round-trip confirmed.

Entry points (8)

  • symptom
    Patient reports gush or persistent leakage of clear or blood-tinged fluid at < 37+0 wk gestation (ACOG PB 217 2024)
    leaking_fluid_history_at_under_37wk
  • symptom
    Amniotic fluid pooling in posterior fornix on sterile speculum exam at < 37+0 wk — gold-standard PPROM diagnostic finding (ACOG PB 217 2024)
    pooling_on_sterile_speculum
  • lab_abnormality
    AmniSure (PAMG-1) or ROM-Plus (PAMG-1 + IGFBP-1) positive assay — sens 98-99 %, spec 87-100 % when speculum equivocal (ACOG PB 217 2024)
    amnisure_or_rom_plus_positive
  • lab_abnormality
    Nitrazine-positive (alkaline pH 7.1-7.3) AND/OR ferning pattern on dried amniotic fluid microscopy — supportive of PPROM (ACOG PB 217 2024)
    nitrazine_or_ferning_positive
  • imaging
    Oligohydramnios (AFI ≤ 5 cm or MVP < 2 cm) on obstetric US — supportive of PPROM in clinical context but does not exclude (ACOG PB 217 2024)
    oligohydramnios_on_ultrasound
  • vital_abnormality
    Maternal fever ≥ 39.0 °C single OR 38.0-38.9 °C × 2 ≥ 30 min apart with confirmed or suspected PPROM → routes to ob.chorioamnionitis.v1 (Higgins NICHD/ACOG/SMFM 2016 PMID 26855098)
    maternal_fever_or_tachycardia_with_pprom
  • symptom
    Foul-smelling or purulent cervical discharge on speculum — Higgins 2016 secondary criterion for suspected chorio in PPROM
    foul_discharge_or_purulent_cervix
  • vital_abnormality
    Sustained fetal heart rate > 160 bpm for ≥ 10 min on continuous EFM with confirmed PPROM — Higgins 2016 secondary criterion for suspected chorio
    fetal_tachycardia_with_pprom

Required inputs (26)

  • gestational_age_weeksrequired
    demographic • used at FRAME
    GA partitions decision branches: < 23 wk previable (counseling-heavy); 23+0 - 25+6 periviable (active management vs termination); 26+0 - 33+6 early preterm (full intervention + expectant); 34+0 - 36+6 late preterm (favor delivery per ACOG PB 217); ≥ 37+0 wk term PROM (out of scope)
  • membrane_status_confirmed_ppromrequired
    history • used at FRAME
    PPROM diagnosis confirmed via sterile speculum (pooling + nitrazine + ferning) OR commercial PAMG-1 assay (AmniSure / ROM-Plus); avoid digital exam until delivery anticipated
  • rom_duration_hoursrequired
    history • used at CONTEXT
    ROM > 18 h is CDC IAP indication + chorio antecedent risk; informs latency-antibiotic timing + chorio surveillance cadence
  • prior_pprom_in_prior_pregnancy
    history • used at CONTEXT
    Recurrence ~ 16-32 % in subsequent pregnancy; preconception MFM consultation for next-pregnancy planning
  • prior_spontaneous_preterm_birth_count_and_GA
    history • used at CONTEXT
    Prior spontaneous PTB increases recurrence risk; relevant for next-pregnancy MFM consultation (not acute decision)
  • multifetal_gestation_statusrequired
    history • used at CONTEXT
    Twin/triplet — PPROM management complicated by shared circulation in monochorionic twins; cord prolapse + abruption risk elevated; MFM co-management
  • maternal_gbs_status_and_iap_adequacyrequired
    history • used at TREATMENT
    GBS-positive OR unknown-GBS + PPROM at any GA → IAP indication; informs penicillin G dosing + alternative-regimen decisions
  • maternal_pen_allergy_severityrequired
    history • used at TREATMENT
    Anaphylaxis → vancomycin or clindamycin (susceptible) for GBS IAP; mild → cefazolin substitute (cross-reactivity ~ 1-2 % per Macy 2014)
  • erythromycin_intolerance_or_qtc_concern
    history • used at TREATMENT
    Erythromycin intolerance (GI), drug shortage, or QTc concerns → azithromycin 1 g PO × 1 as alternative per SMFM 2025
  • fetal_presentation_cephalic_vs_non_cephalicrequired
    history • used at CONTEXT
    Non-cephalic presentation + PPROM + oligohydramnios increases cord prolapse risk; influences delivery planning + ED monitoring
  • cerclage_in_situ_status
    history • used at CONTEXT
    PPROM with cerclage in situ — case-by-case removal decision usually within 24-48 h given ascending infection risk
  • maternal_temperaturerequired
    vital • used at RED_FLAGS
    Fever ≥ 39.0 °C single OR 38.0-38.9 °C × 2 ≥ 30 min apart is gateway chorio criterion per Higgins 2016; routes to ob.chorioamnionitis.v1
  • maternal_hrrequired
    vital • used at CONTEXT
    Maternal tachycardia > 100 supports chorio; sepsis screen if disproportionate to fever
  • maternal_bprequired
    vital • used at RED_FLAGS
    BP screens for superimposed pre-eclampsia + sepsis (hypotension MAP < 65 → emergent resuscitation per SSC 2026 OB adaptation)
  • maternal_rrrequired
    vital • used at CONTEXT
    Tachypnea > 22 is qSOFA component (sepsis flag); magnesium toxicity surveillance (RR < 12)
  • maternal_spo2required
    vital • used at CONTEXT
    Hypoxemia unusual in PPROM — consider PE / pneumonia / AFE differential
  • fetal_heart_rate_baselinerequired
    vital • used at CONTEXT
    FHR > 160 sustained × 10 min with maternal fever is Higgins 2016 chorio secondary criterion; Category III FHR mandates emergent delivery
  • maternal_cbc_with_diffrequired
    lab • used at INITIAL_WORKUP
    WBC > 15K without antenatal steroids is Higgins 2016 chorio secondary criterion; daily during expectant PPROM management
  • maternal_blood_culture_if_sirs
    lab • used at INITIAL_WORKUP
    Bacteremia in chorio ~ 5-10 %; mandatory if SIRS / qSOFA features → routes to id.sepsis.core.v1
  • maternal_urinalysis_and_culturerequired
    lab • used at INITIAL_WORKUP
    Asymptomatic bacteriuria / pyelonephritis common in pregnancy + can trigger preterm contractions; rule out as PPROM mimic + treat if positive
  • cervicovaginal_gbs_culture_if_not_recentrequired
    lab • used at INITIAL_WORKUP
    GBS culture if not done within 5 wk antepartum; informs IAP empirics until result available (treat empirically as GBS-positive when status unknown)
  • maternal_metabolic_panelrequired
    lab • used at INITIAL_WORKUP
    Renal function for magnesium dosing (toxicity if CrCl < 30); baseline before infusion; LFTs for HELLP overlap if PE features
  • maternal_coag_panel
    lab • used at INITIAL_WORKUP
    Pre-procedural workup for cesarean if anticipated; abruption-DIC monitoring if abruption overlay
  • obstetric_ultrasound_growth_and_afirequired
    imaging • used at INITIAL_WORKUP
    Confirm GA + EFW + AFI (oligohydramnios supports PPROM); placenta location for abruption ddx; fetal presentation for cord-prolapse risk + delivery planning
  • continuous_efm_intrapartum_or_admissionrequired
    imaging • used at MONITORING
    Continuous EFM (Category I/II/III) once admitted with PPROM; FHR > 160 sustained is Higgins 2016 chorio criterion; Category III mandates emergent delivery
  • bishop_score_when_delivery_planned
    imaging • used at DISPOSITION
    Bishop score guides induction-vs-cesarean decision at 34+0 wk PPROM or chorio-driven delivery; unfavorable cervix may favor cervical ripening with misoprostol / dinoprostone / Foley balloon

12-phase flow (12)

  1. 1FRAME
    Preterm premature rupture of membranes (PPROM) = spontaneous rupture of fetal membranes at < 37+0 wk of gestation prior to onset of labor. Partition by GA tier (previable < 23 / periviable 23-25+6 / early preterm 26-33+6 / late preterm 34-36+6 / term ≥ 37 = PROM out-of-scope) and chorioamnionitis status (absent: expectant management eligible / present: immediate delivery + ampicillin + gentamicin per ob.chorioamnionitis.v1). Distinguishes from preterm labor with intact membranes (`ob.preterm-labor.v1`), term PROM (≥ 37 wk; routine), placental abruption (painful bleed + tachysystole; `ob.placental-abruption.v1`), and cervical insufficiency (painless 2nd-tri dilation without ROM; `ob.cervical-insufficiency.v1`).
    inputs: gestational_age_weeks, membrane_status_confirmed_pprom
    advance: GA tier + PPROM confirmation (speculum or PAMG-1 assay) documented
  2. 2ENTRY
    Recognise PPROM via patient-reported leak + sterile speculum showing pooling + nitrazine + ferning OR commercial PAMG-1 assay (AmniSure / ROM-Plus) when speculum equivocal. Oligohydramnios on US supports diagnosis. **Avoid digital cervical exam** until delivery anticipated (ascending infection risk per ACOG PB 217 2024).
    inputs: gestational_age_weeks
    advance: PPROM diagnosed; sterile speculum or PAMG-1 confirmation documented
  3. 3CONTEXT
    GA exact + ROM duration + maternal GBS status + IAP adequacy + maternal penicillin allergy severity + erythromycin intolerance / QTc concerns + multifetal status + fetal presentation (cephalic vs non-cephalic; cord prolapse risk) + cerclage in situ + prior PPROM / PTB history + comorbidities (DM, HTN, smoking). Critical decision context for latency antibiotic choice, ANS timing, magnesium indication, GBS IAP regimen, and delivery-vs-expectant decision.
    inputs: gestational_age_weeks, membrane_status_confirmed_pprom, rom_duration_hours, maternal_gbs_status_and_iap_adequacy, maternal_pen_allergy_severity, erythromycin_intolerance_or_qtc_concern, multifetal_gestation_status, fetal_presentation_cephalic_vs_non_cephalic, cerclage_in_situ_status, maternal_hr, maternal_rr, maternal_spo2, fetal_heart_rate_baseline
    advance: Risk-factor profile + GA-tier-specific decision context captured
  4. 4RED_FLAGS
    Maternal fever ≥ 39.0 °C OR 38.0-38.9 °C × 2 + secondary criteria → routes to ob.chorioamnionitis.v1 with PPROM carryover; expedite delivery. Painful vaginal bleeding + tachysystole + tender uterus → ob.placental-abruption.v1; tocolysis CONTRAINDICATED. Cord prolapse on speculum → emergent cesarean per RCOG GTG 50 + manual elevation + terbutaline tocolytic adjunct. Non-reassuring FHR Category III → emergent delivery. Severe HTN ≥ 160/110 + proteinuria → ob.preeclampsia-early-onset.v1. Maternal sepsis (qSOFA ≥ 2 / SIRS ≥ 2 / lactate ≥ 2 / MAP < 65) → emergent delivery + id.sepsis.core.v1 with OB carryover.
    inputs: maternal_temperature, maternal_bp, maternal_hr, fetal_heart_rate_baseline
    actions: protocol.septic_shock
    advance: Red-flag routing decisions documented (chorio / abruption / cord prolapse / Cat III FHR / severe PE / sepsis)
  5. 5INITIAL_WORKUP
    Maternal CBC with diff (Higgins 2016 WBC > 15K secondary criterion) + CMP (renal for magnesium dosing) + UA + urine culture (pyelonephritis mimic) + cervicovaginal GBS culture if not recent + coag baseline if cesarean anticipated. Obstetric US for AFI (oligohydramnios supports PPROM) + EFW + placenta location (abruption ddx) + fetal presentation (cord prolapse risk). Continuous EFM once admitted. Document GA exactly (23+0 / 26+0 / 32+0 / 34+0 are decision-tier boundaries).
    inputs: maternal_cbc_with_diff, maternal_metabolic_panel, maternal_urinalysis_and_culture, cervicovaginal_gbs_culture_if_not_recent, obstetric_ultrasound_growth_and_afi
    actions: workup.preeclampsia, panel.cbc, panel.renal, panel.ua
    advance: Diagnostic labs + imaging drawn; GA tier confirmed; chorio surveillance baseline established
  6. 6BRANCHING_WORKUP
    Branching by GA tier + chorioamnionitis status + abruption/cord-prolapse overlay. Previable < 23 wk: periviable counseling per ACOG/SMFM OCC 6 (2017); expectant vs termination. Periviable 23-25+6 wk: active management if chosen — latency abx + ANS + magnesium + IAP. Early preterm 26-33+6: full intervention; goal latency to 34 wk. Late preterm 34-36+6: deliver per ACOG PB 217 2024 (induction or expectant). Any GA + chorio: immediate delivery + ampicillin + gentamicin. Any GA + abruption: emergent delivery + MTP. Any GA + cord prolapse: emergent cesarean. Amniocentesis selectively for suspected subclinical IAI (rare; consider for puzzling chorio-like presentations).
    inputs: maternal_blood_culture_if_sirs, maternal_coag_panel
    actions: workup.fuo
    advance: GA-tier-specific + overlay-specific treatment plan documented; branching decisions complete
  7. 7DIFFERENTIAL
    Urinary incontinence (common in pregnancy; nitrazine-negative + ferning-negative + PAMG-1 negative); vaginal discharge (BV, candidiasis; speculum + wet mount + KOH); cervical mucus / show with cervical change (PTL with intact membranes — routes to ob.preterm-labor.v1); placental abruption (painful bleed + tachysystole + tender uterus — routes to ob.placental-abruption.v1); chorioamnionitis (fever + Higgins 2016 — routes to ob.chorioamnionitis.v1 if PPROM confirmed with chorio overlay); pyelonephritis (UA + urine culture; can present with contractions); rupture of subchorionic hematoma (small amount of bloody fluid that may mimic PPROM); semen, urine, blood mimicking nitrazine positivity (false-positive avoidance).
    advance: Mimics excluded or co-managed; PPROM confirmation diagnostic + tier-specific plan set
  8. 8RISK_STRATIFICATION
    GA tier + chorio status + fetal status (Category I/II/III) + AFI + fetal presentation drives imminence: high-risk (chorio confirmed OR abruption OR cord prolapse OR Cat III FHR) → emergent delivery; moderate-risk (early preterm + expectant management feasible) → full admission + intervention with chorio surveillance; lower-risk (34+0 - 36+6 + stable) → delivery (induction or expectant per local protocol). Previable < 23 wk → counseling-heavy pathway. qSOFA / SIRS / lactate screen for sepsis if febrile.
    inputs: gestational_age_weeks, maternal_temperature, fetal_heart_rate_baseline
    actions: calc.qsofa, calc.sirs
    advance: Imminence tier set; admit-vs-discharge-vs-deliver decision documented
  9. 9TREATMENT
    LATENCY ANTIBIOTICS (PPROM < 34 wk + expectant management + no chorio): ampicillin 2 g IV q6h × 48 h then amoxicillin 250 mg PO q8h × 5 d + erythromycin 250 mg IV q6h × 48 h then 333 mg PO q8h × 5 d (total 7 d; NICHD-MFMU Mercer JAMA 1997 PMID 9307346). Azithromycin 1 g PO × 1 alternative per SMFM 2025 if erythromycin intolerance / drug shortage / QTc concern. AVOID amoxicillin-clavulanate (NEC per ORACLE-II Kenyon 2008). ANTENATAL CORTICOSTEROIDS (23+0 - 33+6 wk + delivery anticipated within 7 d): betamethasone 12 mg IM q24h × 2 doses OR dexamethasone 6 mg IM q12h × 4 doses (ACOG CO 713; Roberts Cochrane 2017 PMID 28321847). Rescue course per ACOG 2024 if > 14 d since prior + still < 34 wk + new imminent delivery. Late preterm 34+0 - 36+6 wk: betamethasone × 2 per ALPS NEJM 2016 PMID 26842679 IF no prior course + delivery anticipated within 7 d + low chorio risk (less commonly applied in PPROM ≥ 34 wk where delivery is favored). MAGNESIUM NEUROPROTECTION (< 32 wk + imminent delivery): 4-6 g IV load over 20-30 min + 1 g/h × 12-24 h (BEAM NEJM 2008 PMID 18753646; Doyle Cochrane 2009 PMID 19160238). TOCOLYSIS: relative contraindication in PPROM; brief use (≤ 48 h) ONLY for ANS window completion in absence of chorio / abruption / non-reassuring fetal status (most experts avoid even brief tocolysis per ACOG PB 217). GBS IAP intrapartum: penicillin G 5 mU IV load → 2.5-3 mU q4h until delivery (or ampicillin 2 g + 1 g q4h; cefazolin 2 g + 1 g q8h mild pen-allergy; clindamycin 900 mg q8h IV if susceptible / vancomycin 20 mg/kg IV q8h for severe pen-allergy per CDC Verani 2010 + ACOG CO 797 2020). DELIVERY TIMING: ≥ 34+0 wk OR chorio OR abruption OR cord prolapse OR Cat III FHR → induction or cesarean per local protocol + cervical favorability (Bishop score). Acetaminophen 650-1000 mg PO/IV q6h PRN for maternal pain or fever; avoid NSAIDs intrapartum (PDA constriction + bleeding).
    inputs: gestational_age_weeks, maternal_gbs_status_and_iap_adequacy, maternal_pen_allergy_severity
    advance: Latency antibiotics, ANS (if indicated), magnesium (if < 32 wk + imminent), IAP plan, and delivery-vs-expectant decision documented and started
  10. 10DISPOSITION
    L&D / antepartum admission for all PPROM at < 37 wk (most patients). Periviable counseling consultation if < 23 wk (ACOG/SMFM OCC 6 2017). Tertiary transfer if < 32 wk and current facility lacks NICU. ICU only if maternal sepsis / pulmonary edema / multi-organ dysfunction. Outpatient expectant management of PPROM in selected stable patients is emerging but NOT standard practice. Delivery at ≥ 34+0 wk via induction or expectant per ACOG PB 217 + cervical favorability (Bishop score). Cesarean for chorio + non-reassuring FHR OR cord prolapse OR abruption.
    inputs: gestational_age_weeks, maternal_bp, maternal_spo2, bishop_score_when_delivery_planned
    advance: Maternal level of care set; NICU coordination if delivery anticipated; tertiary-transfer decision if indicated
  11. 11MONITORING
    Continuous EFM intrapartum (Category I/II/III); maternal vitals q15 min during active labor or magnesium loading; q1 h post-load; q4 h stable. Magnesium toxicity surveillance hourly (DTR + RR + UO; STOP + calcium gluconate 1 g IV antidote if RR < 12 / DTR loss / UO < 0.5 mL/kg/h). Maternal temperature q4 h (chorio surveillance). Daily CBC + CMP during expectant PPROM management. Weekly AFI surveillance + fetal growth q2-4 wk during expectant management. Continuous EFM during corticosteroid + magnesium load (transient FHR variability reduction expected).
    inputs: maternal_temperature, maternal_hr, maternal_rr, fetal_heart_rate_baseline, continuous_efm_intrapartum_or_admission
    actions: panel.cbc, panel.renal
    advance: Maternal-fetal status stable + no chorio emergence + ANS window completed (48 h) OR delivered with appropriate neonatal coordination
  12. 12FOLLOWUP
    6-wk postpartum visit + PPROM-specific anticipatory guidance: recurrence ~ 16-32 % in subsequent pregnancy; preconception MFM consultation for next-pregnancy planning (early TVUS CL surveillance, vaginal progesterone planning if short cervix, cerclage indication review). Mental health screen (EPDS for postpartum depression; PCL-5 for peripartum PTSD especially after extreme preterm or NICU outcomes). Contraception counseling + interpregnancy interval ≥ 18 mo. Immunization audit (Tdap, flu, COVID per ACIP). Newborn outpatient peds visit 24-48 h post-discharge if late preterm; first-year developmental tracking if very preterm or extreme preterm.
    advance: Postpartum visit complete; preconception MFM counseling delivered; mental health + immunization + newborn developmental tracking arranged